Amid financial turbulence and rumors of an imminent sale of assets to pare its debt pile, India's Wockhardt Ltd. gave its investors something to cheer about in the new year.
The Mumbai-based firm has received regulatory approval in India for two indigenously developed novel antibiotics, essentially broad spectrum anti-MRSA drugs,...







